LSP Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

LSP Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,500	Closed	-$1.53M	–	26
2024 Q3	$1.53M	Hold	15,500	–	–	0.82%	15
2024 Q2	$1.44M	Hold	15,500	–	–	0.82%	16
2024 Q1	$1.47M	Hold	15,500	–	–	0.79%	14
2023 Q4	$1.38M	Hold	15,500	–	–	0.65%	13
2023 Q3	$1.13M	Hold	15,500	–	–	0.56%	11
2023 Q2	$1.29M	Hold	15,500	–	–	0.72%	11
2023 Q1	$1.18M	Hold	15,500	–	–	0.66%	13
2022 Q4	$1.29M	Hold	15,500	–	–	0.57%	13
2022 Q3	$1.23M	Hold	15,500	–	–	0.52%	15
2022 Q2	$1.15M	Buy	+15,500	New	+$1.16M	0.45%	16

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

LSP Investment Advisors's XBI Position: Q4 2024 in Review

LSP Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 15,500 shares — an estimated $1.53M sold.

LSP Investment Advisors first reported a position in XBI in Q2 2022 and held it in 10 quarters. The position peaked at $1.53M in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

LSP Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
LSP Investment Advisors sold 15,500 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $1.53M.
LSP Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 10 quarters.
LSP Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.53M in Q3 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on LSP Investment Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.